Drug Combination Details
General Information of the Combination (ID: C93281) | |||||
---|---|---|---|---|---|
Name | Flavopiridol NP Info | + | Mitomycin C Drug Info | ||
Structure | + | ||||
Disease |
Stomach cancer
[ICD-11: 2B72]
|
Investigative | [1] | ||
Breast cancer
[ICD-11: 2C60]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Enhancing Drug Efficacy by This Combination | ||||||
Augmenting Drug Sensitivity | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
In-vitro Model | MKN74 | CVCL_2791 | Gastric tubular adenocarcinoma | Homo sapiens | ||
MDA-MB-468 | CVCL_0419 | Breast adenocarcinoma | Homo sapiens | |||
Experimental
Result(s) |
Flavopiridol potentiates the cytotoxic effect of the chemotherapeutic agent MMC by promoting drug-induced apoptosis in tumor cells. |
References | ||||
---|---|---|---|---|
Reference 1 | Potentiation of apoptosis by flavopiridol in mitomycin-C-treated gastric and breast cancer cells. Clin Cancer Res. 1997 Sep;3(9):1467-72. |